Having both conditions does not automatically mean one caused the other
While the Phase 2 trial did not specifically stratify outcomes by baseline eGFR, GLP-1 receptor agonists as a class have demonstrated renoprotective effects in at-risk populations
The Peptide Handbook: BPC-157, TB-500, IGF-1 LR3 and AOD-9604 A Beginner's Research Guide to Peptide Therapy for Healing, Recovery, and Biohacking eBook : HEARN, DA : Amazon.in: Kindle Store
Compartment syndrome can develop at injection sites in leg muscles, causing numbness, blood clots and muscle spasms that result in permanent loss of function
Complementary Mechanisms The rationale for combining TB-500 and BPC-157 in research is based on their largely non-overlapping mechanisms: TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide that acts primarily through actin polymerisation regulation